Skip to main content

Dyne Therapeutics, Inc.

DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818794

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Dyne Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of DYN: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1692193+26
Shares95.4M36.7K111.0M+15.6M (+16.4%)
Value$2.71B$1.04M$3.92B+$1.21B (+44.7%)

2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (47)

Institutions that held Dyne Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to DYN in Q2 2024
InstitutionSharesValue% of portfolio
Holocene Advisors, LP2,076,352$73.3M0.31%
Eventide Asset Management, LLC485,000$17.1M0.29%
LMR Partners LLP477,000$16.8M0.36%
Lord, Abbett & Co. LLC452,213$16.0M0.05%
Pictet Asset Management Holding SA294,748$10.4M0.01%
Vestal Point Capital, LP225,000$7.94M0.59%
Soleus Capital Management, L.P.201,000$7.09M0.63%
EAM Global Investors LLC127,247$4.49M1.01%
Renaissance Technologies LLC126,000$4.45M0.01%
Avoro Capital Advisors LLC115,751$4.08M0.05%
Affinity Asset Advisors, LLC100,000$3.53M0.56%
Integral Health Asset Management, LLC100,000$3.53M0.35%
BCJ Capital Management, LLC99,959$3.53M0.28%
D. E. Shaw & Co., Inc.88,420$3.12M0.00%
Walleye Capital LLC85,652$3.02M0.03%
Mutual of America Capital Management LLC48,845$1.72M0.02%
Corebridge Financial, Inc.43,414$1.53M0.01%
Mirae Asset Global ETFs Holdings Ltd.39,640$1.40M0.00%
Cinctive Capital Management LP34,529$1.22M0.07%
First Trust Advisors LP27,821$981.8K0.00%
Virtue Capital Management, LLC22,227$974.7K0.17%
Ameriprise Financial Inc26,028$918.5K0.00%
Alyeska Investment Group, L.P.25,000$882.3K0.01%
Omers Administration Corp23,600$832.8K0.01%
State Board of Administration of Florida Retirement System20,605$727.1K0.00%
Victory Capital Management Inc19,152$675.9K0.00%
Standard Life Aberdeen plc17,869$630.6K0.00%
Gilder Gagnon Howe & Co LLC17,546$619.2K0.01%
Genesee Capital Advisors, LLC16,359$577.3K0.28%
Handelsbanken Fonder AB15,900$561.0K0.00%
PEAK6 Investments LLC15,400$543.5K0.03%
Privium Fund Management B.V.14,016$485.7K0.12%
Alpine Global Management, LLC12,460$439.7K0.08%
Brevan Howard Capital Management LP10,053$354.8K0.02%
FORA Capital, LLC8,222$290.2K0.04%
Creative Planning7,494$264.5K0.00%
Compagnie Lombard Odier SCmA7,000$247.0K0.00%
American Century Companies Inc6,451$227.7K0.00%
SG Americas Securities, LLC6,137$217.0K0.00%
Farallon Capital Management, L.L.C.6,000$211.7K0.00%
Public Employees Retirement Association of Colorado5,740$203.0K0.00%
Mirabella Financial Services LLP5,698$201.1K0.01%
First Horizon Advisors, Inc.153$5.40K0.00%
Innealta Capital, LLC81$2.86K0.00%
Smartleaf Asset Management LLC32$1.13K0.00%
Parallel Advisors, LLC27$9530.00%
Allworth Financial LP5$2080.00%

Sold out (21)

Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (2)

Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DYN in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Credit Suisse AG36,383$1.03M
Cutler Group LP300$8.00K